Kitahara A, Satoh K, Nishimura K, Ishikawa T, Ruike K, Sato K, Tsuda H, Ito N
Cancer Res. 1984 Jun;44(6):2698-703.
Changes in molecular forms of hepatic cytosolic glutathione S-transferases (GST) during rat chemical hepatocarcinogenesis were investigated. GST activities toward 1-chloro-2,4-dinitrobenzene and 1,2-dichloro-4-nitrobenzene increased with the increased area of gamma-glutamyltranspeptidase-positive foci and hyperplastic nodules induced by diethylnitrosamine followed by 2-acetylaminofluorene plus hepatectomy. Among GSTs with high activities toward 1,2-dichloro-4-nitrobenzene, which were separated by carboxymethyl Sephadex column chromatography, the activity of GST-A ( YbYb ) markedly increased with increased activity towards 1,2-dichloro-4-nitrobenzene in livers bearing foci and nodules and in isolated nodules and hepatomas, while activities of GST-C ( YbYb ') and -D (Yb'Yb') changed little. It was demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and two-dimensional gel electrophoresis that Yb as well as Ya , a subunit of ligandin ( YaYa ) and GST-B ( YaYc ), increased in livers bearing foci and nodules, while Yc as well as Yb' changed little. A new placental GST form (GST-P), which has a subunit molecular weight of 21,500 or 26,000, according to the marker proteins used, and neutral pls of 6.8 and 6.3, is immunologically different from any form of basic GSTs and is very low in normal liver; also, it was markedly induced in livers bearing foci and nodules and in well-differentiated hepatomas but not by short-term administration of drugs such as 2-acetylaminofluorene, in contrast to GST-A and ligandin. These results indicate that GST-A and more especially GST-P could be new preneoplastic marker enzymes for chemical hepatocarcinogenesis.
研究了大鼠化学性肝癌发生过程中肝细胞溶质谷胱甘肽S-转移酶(GST)分子形式的变化。经二乙基亚硝胺诱导,随后用2-乙酰氨基芴加肝切除术诱发γ-谷氨酰转肽酶阳性灶和增生性结节,随着其面积的增加,GST对1-氯-2,4-二硝基苯和1,2-二氯-4-硝基苯的活性增强。在用羧甲基葡聚糖凝胶柱色谱法分离出的对1,2-二氯-4-硝基苯具有高活性的GST中,GST-A(YbYb)的活性在有灶和结节的肝脏以及分离出的结节和肝癌中,随着对1,2-二氯-4-硝基苯活性的增加而显著升高,而GST-C(YbYb')和-D(Yb'Yb')的活性变化很小。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和二维凝胶电泳证明,有灶和结节的肝脏中Yb以及配体蛋白(YaYa)和GST-B(YaYc)的亚基Ya增加,而Yc以及Yb'变化很小。一种新的胎盘GST形式(GST-P),根据所用的标记蛋白,其亚基分子量为21,500或26,000,中性等电点为6.8和6.3,在免疫上与任何形式的碱性GST不同,在正常肝脏中含量很低;此外,与GST-A和配体蛋白不同,它在有灶和结节的肝脏以及高分化肝癌中显著诱导,但不受2-乙酰氨基芴等药物短期给药的诱导。这些结果表明,GST-A尤其是GST-P可能是化学性肝癌发生的新的癌前标记酶。